The drug discovery process is famously complex ... The development of more sophisticated disease models and the application of artificial intelligence in drug design are just two examples of the ...

Insilico Medicine (“Insilico”), a clinical-stage generative artificial intelligence (AI)-driven biotechnology company, today ...

Biotech firm Iambic Therapeutics unveiled on Tuesday what it says is a breakthrough artificial intelligence model ... published details of its new AI drug discovery model, named "Enchant".

The global AI in pathology market is projected to reach USD 169.8 million by 2029 from USD 82.8 million in 2024, at a high ...

and it could help us not only interact more effectively with artificial intelligence, but even improve ...

Anyone following the rhetoric around artificial intelligence in recent years has heard one version or another of the claim that AI is inevitable. Common themes are that AI is already here, it is ...

Find out what AI has already brought to Alzheimer's disease research and most importantly, what it can accomplish in the ...

Although the rise of artificial intelligence (AI ... been increasingly disclosing risk factors related to life sciences companies using AI in drug development and related activities in SEC ...

Biotech firm Iambic Therapeutics unveiled on Tuesday what it says is a breakthrough artificial intelligence model ... published details of its new AI drug discovery model, named "Enchant".

Microsoft’s newest update gives a conversational voice to its artificial intelligence companion ... breaks down how AI-generated videos and images are impacting the election and how to ...

Another Trump presidency will be good for crypto and Elon Musk, but every big tech company may not benefit from a more hands-off approach to antitrust. By Kevin Roose The shift in policy ...